Skip to main content
Watch Insiders
MLYSHealthcare

Mineralys Therapeutics Inc (MLYS) Insider Trading

In the last 90 days, 5 Mineralys Therapeutics Inc (MLYS) insiders reported no open-market purchases and 6 sales totaling $5,461,817. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 30, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 30, 2026Jon CongletonChief Executive OfficerSale75,000$25.46$1,909,665
Sep 22, 2026Brian Taylor SlingsbyCorporate insiderSale104,320$28.81$3,005,303
Sep 21, 2026Eric WarrenChief Commercial OfficerSale7,438$28.12$209,136
Sep 15, 2026Daphne KarydasCorporate insiderSale3,000$28.58$85,740
Aug 21, 2026Eric WarrenChief Commercial OfficerSale7,437$25.98$193,189
Aug 10, 2026David Malcom RodmanChief Medical OfficerSale2,170$27.09$58,785
Jul 21, 2026Eric WarrenChief Commercial OfficerSale7,438$26.87$199,885
Jul 17, 2026David Malcom RodmanChief Medical OfficerSale416$26.53$11,036
Jul 15, 2026David Malcom RodmanChief Medical OfficerSale20,407$27.28$556,672
Jul 13, 2026Jon CongletonChief Executive OfficerSale10,700$27.24$291,441
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

MLYS insider trading FAQ

Are MLYS insiders buying or selling?
Over the last 90 days, MLYS insiders were net sellers, reporting $0.00 of open-market purchases and $5,461,817 of sales.
When was the last MLYS insider purchase?
No open-market insider purchase of Mineralys Therapeutics Inc stock was reported in the last 90 days.
Where does MLYS insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Mineralys Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.